<DOC>
	<DOCNO>NCT01054092</DOCNO>
	<brief_summary>The primary objective study evaluate long-term safety ASP1941 patient type 2 diabetes mellitus . The second objective compare efficacy pharmacokinetics ASP1941 administer food intake .</brief_summary>
	<brief_title>A Study Assess Long-term Safety Efficacy ASP1941 Japanese Diabetic Patients</brief_title>
	<detailed_description>Subject randomize either ASP1941 meal ASP1941 meal group . Subjects undergo screening period enter long-term treatment . Dosage may increase treatment period subject fulfill increase criterion investigator adjudicate impact subject safety .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Type 2 diabetic patient least 12 week HbA1c value 6.5 9.5 % Body Mass Index ( BMI ) 20.0 45.0kg/m2 Type 1 diabetes mellitus patient Serum creatinine &gt; upper limit normal Proteinuria ( albumin/creatinine ratio &gt; 300mg/g ) Dysuria and/or urinary tract infection , genital infection Significant renal , hepatic cardiovascular disease Severe gastrointestinal disease Proliferative diabetic retinopathy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>ASP1941</keyword>
	<keyword>Diabetes mellitus</keyword>
	<keyword>Blood glucose</keyword>
	<keyword>Food effect</keyword>
</DOC>